Evidence map›Paper›PMID 39911172›Full record

ArticleMolecular syndromology2025

A Novel Truncating Variant in Sandestig-Stefanova Syndrome with Hydrocephalus.

Gülnihal Bulut, Gözde Tutku Turgut, Güven Toksoy, Umut Altunoğlu, Ayça Dilruba Aslanger, Zehra Oya Uyguner, Birsen Karaman

Abstract read
In one paragraph

Article in Molecular syndromology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gülnihal BulutDepartment of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
Gözde Tutku TurgutDepartment of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
Güven ToksoyDepartment of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
Umut AltunoğluDepartment of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
Ayça Dilruba AslangerDepartment of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
Zehra Oya UygunerDepartment of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
Birsen KaramanDepartment of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Sandestig-Stefanova syndrome (MIM:618804) is characterized by pre- and postnatal microcephaly, trigonocephaly, bilateral congenital cataracts, microphthalmia, cleft lip and palate or high-arched palate, camptodactyly, rocker-bottom feet, heart anomalies, periventricular white matter loss, thin corpus callosum, and delayed myelination. Bi-allelic loss-of-function variants in the Case Presentation: Our patient, born to consanguineous parents, presented with tetralogy of Fallot, bilateral congenital cataracts, hydrocephalus, a bifid uvula, a right pelvic kidney, hepatomegaly, facial feature findings, and a history of a similarly affected ex-sibling. Whole exome sequence analysis in the index case revealed a novel homozygous variant NM_015354.2: c.124C>T/p.(Arg42Ter) in the Conclusion: This study describes a new patient with Sandestig-Stefanova syndrome harboring a novel pathogenic variant in the

Indexed as

Autosomal recessiveHydrocephalusNovel mutationNUP188Whole exome sequencing

Identifiers

PMID39911172
PMCPMC11793897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.